SUNNOVA ENERGY INTERNATIONAL (NOVA)

US86745K1043 - Common Stock

4  +0.32 (+8.7%)

After market: 3.96 -0.04 (-1%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to NOVA. NOVA was compared to 21 industry peers in the Independent Power and Renewable Electricity Producers industry. NOVA has a bad profitability rating. Also its financial health evaluation is rather negative. NOVA is quite expensive at the moment. It does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

NOVA had negative earnings in the past year.
NOVA had a negative operating cash flow in the past year.
NOVA had negative earnings in each of the past 5 years.
NOVA had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

NOVA has a Return On Assets of -3.69%. This is in the lower half of the industry: NOVA underperforms 71.43% of its industry peers.
NOVA's Return On Equity of -27.37% is on the low side compared to the rest of the industry. NOVA is outperformed by 80.95% of its industry peers.
Industry RankSector Rank
ROA -3.69%
ROE -27.37%
ROIC N/A
ROA(3y)-2.71%
ROA(5y)-4.39%
ROE(3y)-17.23%
ROE(5y)-20.87%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

NOVA has a Gross Margin (40.68%) which is in line with its industry peers.
In the last couple of years the Gross Margin of NOVA has declined.
NOVA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.68%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.88%
GM growth 5Y-8.9%

0

2. Health

2.1 Basic Checks

NOVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NOVA has been increased compared to 1 year ago.
The number of shares outstanding for NOVA has been increased compared to 5 years ago.
The debt/assets ratio for NOVA is higher compared to a year ago.

2.2 Solvency

NOVA has an Altman-Z score of -0.02. This is a bad value and indicates that NOVA is not financially healthy and even has some risk of bankruptcy.
NOVA's Altman-Z score of -0.02 is on the low side compared to the rest of the industry. NOVA is outperformed by 61.90% of its industry peers.
NOVA has a Debt/Equity ratio of 4.61. This is a high value indicating a heavy dependency on external financing.
NOVA has a Debt to Equity ratio of 4.61. This is in the lower half of the industry: NOVA underperforms 71.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.61
Debt/FCF N/A
Altman-Z -0.02
ROIC/WACCN/A
WACC4.38%

2.3 Liquidity

A Current Ratio of 0.85 indicates that NOVA may have some problems paying its short term obligations.
With a Current ratio value of 0.85, NOVA is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
NOVA has a Quick Ratio of 0.85. This is a bad value and indicates that NOVA is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.72, NOVA is doing worse than 76.19% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.85
Quick Ratio 0.72

6

3. Growth

3.1 Past

The earnings per share for NOVA have decreased strongly by -153.73% in the last year.
Looking at the last year, NOVA shows a very strong growth in Revenue. The Revenue has grown by 29.22%.
The Revenue has been growing by 47.17% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-153.73%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-694.44%
Revenue 1Y (TTM)29.22%
Revenue growth 3Y64.87%
Revenue growth 5Y47.17%
Revenue growth Q2Q-0.72%

3.2 Future

NOVA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.56% yearly.
NOVA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 23.85% yearly.
EPS Next Y35.57%
EPS Next 2Y21.34%
EPS Next 3Y14.73%
EPS Next 5Y8.56%
Revenue Next Year30.44%
Revenue Next 2Y28.85%
Revenue Next 3Y27.91%
Revenue Next 5Y23.85%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NOVA. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NOVA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

NOVA's earnings are expected to grow with 14.73% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.34%
EPS Next 3Y14.73%

0

5. Dividend

5.1 Amount

NOVA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SUNNOVA ENERGY INTERNATIONAL

NYSE:NOVA (4/26/2024, 7:06:44 PM)

After market: 3.96 -0.04 (-1%)

4

+0.32 (+8.7%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap495.36M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.69%
ROE -27.37%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 40.68%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 4.61
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.85
Quick Ratio 0.72
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-153.73%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y35.57%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)29.22%
Revenue growth 3Y64.87%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y